Loading…

Continuous venetoclax in treatment‐naive TP53 disrupted patients with chronic lymphocytic leukemia: A chronic lymphocytic leukemia campus study

Saved in:

Bibliographic Details
Published in:	American journal of hematology 2023-09, Vol.98 (9), p.E237-E240
Main Authors:	Visentin, Andrea, Mauro, Francesca Romana, Scarfò, Lydia, Gentile, Massimo, Farina, Lucia, Reda, Gianluigi, Ferrarini, Isacco, Proietti, Giulia, Derenzini, Enrico, Cibien, Francesca, Vitale, Candida, Sanna, Alessandro, Pietrasanta, Daniela, Marchetti, Monia, Murru, Roberta, Rigolin, Gian Matteo, Sportoletti, Paolo, Trimarco, Valentina, Cavarretta, Chiara Adele, Angotzi, Francesco, Cellini, Alessandro, Ruocco, Valeria, Zatta, Ivan, Laurenti, Luca, Molica, Stefano, Coscia, Marta, Ghia, Paolo, Foà, Robin, Cuneo, Antonio, Trentin, Livio
Format:	Article
Language:	English
Subjects:	Antineoplastic Agents - therapeutic use Antineoplastic Combined Chemotherapy Protocols - adverse effects Bridged Bicyclo Compounds, Heterocyclic - therapeutic use Chronic lymphocytic leukemia Hematology Humans Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy Leukemia, Lymphocytic, Chronic, B-Cell - genetics Lymphatic leukemia Sulfonamides - therapeutic use Tumor Suppressor Protein p53 - genetics
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!